StockData
Omada Health, Inc. logo

Omada Health, Inc. (OMDA) stock

OMDANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 13/3056% above fair value
$14.33−0.37 (-2.52%)

Close on Nov 13, 2026Market cap $877.24MP/E –Yield –

Earnings

Omada Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 4, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$91.00M
+33.8% on a year earlier
EPS, Q3 FY2026
$0.10
-$0.06 a year earlier
Latest guidance
Raised
Nov 5, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Omada Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 4, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$91.00M+33.8%$0.10Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$88.00M+44.3%$0.08Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close$78.00M––Release
Q4 FY2025ended Dec 31, 2025Mar 5, 2026after the close$76.00M–$0.08Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$68.00M–-$0.06Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close$61.00M––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Omada Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenueGAAPFY2026$344.00M – $346.00M–NewNov 5, 2026
RevenueFY2026$334.00M – $340.00M$322.00M – $330.00MRaisedAug 6, 2026
RevenueFY2026$312.00M – $322.00M–NewMar 5, 2026
Adjusted EBITDAnon-GAAPFY2026$32.00M – $34.00M$7.00M – $15.00MRaisedNov 5, 2026
Adjusted EBITDAnon-GAAPFY2026$21.00M – $27.00M$14.00M – $20.00MRaisedAug 6, 2026

Guidance history

Every forecast Omada Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026Adjusted EBITDAFY2026$32.00M – $34.00MRaised
Nov 5, 2026RevenueFY2026$344.00M – $346.00MNew
Aug 6, 2026Adjusted EBITDAFY2026$21.00M – $27.00MRaised
Aug 6, 2026RevenueFY2026$334.00M – $340.00MRaised
May 7, 2026Adjusted EBITDAFY2026$14.00M – $20.00MNew
May 7, 2026RevenueFY2026$322.00M – $330.00MNew
Mar 5, 2026Adjusted EBITDAFY2026$7.00M – $15.00MNew
Mar 5, 2026RevenueFY2026$312.00M – $322.00MNew
Nov 6, 2025RevenueFY2025$251.50M – $254.50MNew
Aug 7, 2025Adjusted EBITDA lossFY2025-$9.00M – -$5.00MNew
Aug 7, 2025RevenueFY2025$235.00M – $241.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Omada Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Omada Health Reports Third Quarter 2026 Results
    Results
  2. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition
    Results
  3. Omada Health Reports First Quarter 2026 Results
    Results
  4. Omada Health Reports Fourth Quarter and Full-Year 2025 Results
    Results
  5. Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025
    Results
  6. Omada Health Reports Third Quarter 2025 Results
    Results
  7. Omada Health Reports Second Quarter 2025 Results
    Results

See a number that looks wrong?